All Stories

  1. Synergistic Role of Thymoquinone on Anticancer Activity of 5-Fluorouracil in Triple Negative Breast Cancer Cells
  2. LPS/TLR4 Pathways in Breast Cancer: Insights into Cell Signalling
  3. Major Drugs Used in COVID-19 Treatment: Molecular Mechanisms, Validation and Current Progress in Trials
  4. Biological Role of AKT and Regulation of AKT Signaling Pathway by Thymoquinone: Perspectives in Cancer Therapeutics
  5. Targeting Inflammatory Mediators: An Anticancer Mechanism of Thymoquinone Action
  6. Current Landscape of Natural Products against Coronaviruses: Perspectives in COVID-19 Treatment and Anti-viral Mechanism
  7. Cordycepin in Anticancer Research: Molecular Mechanism of Therapeutic Effects
  8. Characterization and molecular cloning of novel isoforms of human spermatogenesis associated gene SPATA3
  9. A novel splicing mutation in the PRPH2 gene causes autosomal dominant retinitis pigmentosa in a Chinese pedigree
  10. Novel splicing variant c. 208+2T>C in BBS5 segregates with Bardet–Biedl syndrome in an Iranian family by targeted exome sequencing
  11. Cordycepin Downregulates Cdk-2 to Interfere with Cell Cycle and Increases Apoptosis by Generating ROS in Cervical Cancer Cells: in vitro and in silico Study
  12. Thymoquinone Inhibits the Migration and Invasive Characteristics of Cervical Cancer Cells SiHa and CaSki In Vitro by Targeting Epithelial to Mesenchymal Transition Associated Transcription Factors Twist1 and Zeb1
  13. Evaluation of amplification refractory mutation system (ARMS) technique for quick and accurate prenatal gene diagnosis of CHM variant in choroideremia
  14. Genetic identification and molecular modeling characterization reveal a novel PROM1 mutation in Stargardt4-like macular dystrophy
  15. The negative effects of increasing application rates of biochars on weed outbreak of lentil
  16. Evaluation of PIK3CA mutations as a biomarker in Chinese breast carcinomas from Western China
  17. Thymoquinone, as an anticancer molecule: from basic research to clinical investigation
  18. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion
  19. Tripartite motif containing 28 (TRIM28) promotes breast cancer metastasis by stabilizing TWIST1 protein
  20. Genetic Authentication of Gardenia jasminoides Ellis var. grandiflora Nakai by Improved RAPD-Derived DNA Markers
  21. Development of SCAR Markers Based on Improved RAPD Amplification Fragments and Molecular Cloning for Authentication of Herbal Medicines Angelica sinensis, Angelica acutiloba and Levisticum officinale
  22. Establishment of stable cell line for inducing KAP1 protein expression
  23. Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition
  24. Identification of a Novel Heterozygous Missense Mutation in theCACNA1FGene in a Chinese Family with Retinitis Pigmentosa by Next Generation Sequencing
  25. Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer
  26. Twist: a molecular target in cancer therapeutics
  27. ISG15 Inhibits IFN-α-Resistant Liver Cancer Cell Growth